Current Controversies in the Management of Colon Cancer

Current Problems in Surgery

Volumn 49, Issue 7, 2012, Pages 398-460

  Patel, Supriya S ^a   Floyd, Adrienne ^a   Doorly, Michael G ^a   Ortega, Adrian E ^a   Ault, Glenn T ^a   Kaiser, Andreas M ^a   Senagore, Anthony J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; BEVACIZUMAB; CAPECITABINE; CEFALORIDINE; CEFALOTIN; CEFOXITIN; CETUXIMAB; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROMYCIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; GABAPENTIN; IRINOTECAN; KETAMINE; LEVAMISOLE; LOCAL ANESTHETIC AGENT; METFORMIN; METRONIDAZOLE; NARCOTIC ANALGESIC AGENT; NEOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXALIPLATIN; PHTHALYLSULFATHIAZOLE; PLACEBO;

ADENOMATOUS POLYP; ANASTOMOSIS LEAKAGE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BARIUM ENEMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; COLON CANCER; COLON METASTASIS; COLON OBSTRUCTION; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL POLYP; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DOUBLE CONTRAST BARIUM ENEMA; ENDOSCOPIC POLYPECTOMY; ENTERITIS; FAMILIAL ADENOMATOUS POLYPOSIS; FAMILY HISTORY; GENE MUTATION; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTESTINE PREPARATION; LAPAROSCOPIC SURGERY; MULTIPLE CYCLE TREATMENT; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD TEST; OVERALL SURVIVAL; PENETRANCE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE ANALGESIA; PREOPERATIVE CARE; PROGRESSION FREE SURVIVAL; RACE DIFFERENCE; RADIOFREQUENCY ABLATION; ROBOTICS; SEDATION; SELF EXPANDABLE METALLIC STENT; SENTINEL LYMPH NODE BIOPSY; SEX DIFFERENCE; SIDE EFFECT; SIGMOIDOSCOPY; SINGLE INCISION LAPAROSCOPIC SURGERY; STENT; SURGICAL INFECTION; SURGICAL WOUND; SURVIVAL RATE; THORAX RADIOGRAPHY; TUMOR SUPPRESSOR GENE; UNITED STATES; VOMITING; WOUND INFECTION;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTESTINAL OBSTRUCTION; LAPAROSCOPY; PERIOPERATIVE CARE; RISK FACTORS; ROBOTICS; SENTINEL LYMPH NODE BIOPSY; STENTS; UNITED STATES;

EID: 84861986821     PISSN: 00113840     EISSN: 15356337     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2012.03.002     Document Type: Article

References (348)

1. Cancer Facts Figures 2011, Accessed February 29, 2012. http://www.cancer.org/Cancer/ColonandRectumCancer/index.
2. Minna J., Schiller J.H. Harrison's Principles of Internal Medicine 2008, McGraw-Hill, New York.
3. Witschi H. A short history of lung cancer. Toxicol Sci 2001, 64:4-6.
4. SEER Cancer Statistics Review,1975-2004 2007, National Cancer Institute, Bethesda, MD. L. Ries, D. Melbert, M. Krapcho (Eds.).
5. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008, 58:130-160.
6. SEER Cancer Statistics Review, 1975-2008, Accessed February 28, 2012. http://seer.cancer.gov/csr/1975_2008/.
7. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin 2003, 53:5-26.
8. Selby J.V., Friedman G.D., Quesenberry C.P., et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992, 326:653-657.
9. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
10. Kronborg O., Fenger C., Olsen J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471.
11. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000, 343:1603-1607.
12. Zauber A.G., Winawer S.J., O'Brien M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012, 366:687-696.
13. Davis D.M., Marcet J.E., Frattini J.C., et al. Is it time to lower the recommended screening age for colorectal cancer?. J Am Coll Surg 2011, 213:352-361.
14. Chou C.L., Chang S.C., Lin T.C., et al. Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution. Am J Surg 2011, 202:574-582.
15. Cucino C., Buchner A.M., Sonnenberg A. Continued rightward shift of colorectal cancer. Dis Colon Rectum 2002, 45:1035-1040.
16. Weiss J.M., Pfau P.R., O'Connor E.S., et al. Mortality by stage for right-versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-Medicare data. J Clin Oncol 2011, 29:4401-4409.
17. Chao A., Thun M.J., Connell C.J., et al. Meat consumption and risk of colorectal cancer. JAMA 2005, 293:172-182.
18. Phipps A.I., Baron J., Newcomb P.A. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon Cancer Family Registry. Cancer 2011, 117:4948-4957.
19. Vainio H., Weiderpass E. Fruit and vegetables in cancer prevention. Nutr Cancer 2006, 54:111-142.
20. Aune D., Lau R., Chan D.S., et al. Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 2011, 141:106-118.
21. Asano T., McLeod R.S. Dietary fibre for the prevention of colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2002, CD003430.
22. Galeone C., Turati F., La Vecchia C., et al. Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control 2010, 21:1949-1959.
23. Bidel S., Hu G., Jousilahti P., et al. Coffee consumption and risk of colorectal cancer. Eur J Clin Nutr 2010, 64:917-923.
24. Tantamango Y.M., Knutsen S.F., Beeson W.L., et al. Foods and food groups associated with the incidence of colorectal polyps: the Adventist Health Study. Nutr Cancer 2011, 63:565-572.
25. Jedrychowski W., Maugeri U., Popiela T., et al. Case-control study on beneficial effect of regular consumption of apples on colorectal cancer risk in a population with relatively low intake of fruits and vegetables. Eur J Cancer Prev 2010, 19:42-47.
26. Mekary R.A., Wu K., Giovannucci E., et al. Total antioxidant capacity intake and colorectal cancer risk in the Health Professionals Follow-up Study. Cancer Causes Control 2010, 21:1315-1321.
27. Kennedy D.A., Stern S.J., Moretti M., et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol 2011, 35:2-10.
28. Ma Y., Zhang P., Wang F., et al. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 2011, 29:3775-3782.
29. Touvier M., Chan D.S., Lau R., et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011, 20:1003-1016.
30. Davis S., Mirick D.K. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 2006, 17:539-545.
31. Brudnowska J., Peplonska B. [Night shift work and cancer risk: a literature review]. Med Pr 2011, 62:323-338.
32. Boyle T., Fritschi L., Heyworth J., et al. Long-term sedentary work and the risk of subsite-specific colorectal cancer. Am J Epidemiol 2011, 173:1183-1191.
33. Hassan C., Pickhardt P.J., Marmo R., et al. Impact of lifestyle factors on colorectal polyp detection in the screening setting. Dis Colon Rectum 2010, 53:1328-1333.
34. Kuchiba A., Morikawa T., Yamauchi M., et al. Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Natl Cancer Inst 2012, 104(5):415-420.
35. Yuhara H., Steinmaus C., Cohen S.E., et al. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?. Am J Gastroenterol 2011, 106:1911-1921. quiz 1922.
36. Deng L., Gui Z., Zhao L., et al. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 2012, [Epub ahead of print].
37. Jiang Y., Ben Q., Shen H., et al. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 2011, 26:863-876.
38. Lee J.H., Kim T.I., Jeon S.M., et al. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. Int J Cancer 2011, [Epub ahead of print].
39. Bodmer M., Becker C., Meier C., et al. Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2012, 21:280-286.
40. Zhang X., Smith-Warner S.A., Chan A.T., et al. Aspirin use, body mass index, physical activity, plasma C-peptide, and colon cancer risk in US health professionals. Am J Epidemiol 2011, 174:459-467.
41. Ruder E.H., Laiyemo A.O., Graubard B.I., et al. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 2011, 106:1340-1350.
42. Ali R., Toh H.C., Chia W.K., et al. The utility of aspirin in dukes C and high risk dukes B colorectal cancer-the ASCOLT study: study protocol for a randomized controlled trial. Trials 2011, 12:261.
43. Kedika R., Patel M., Pena Sahdala H.N., et al. Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps. J Clin Gastroenterol 2011, 45:e12-e16.
44. Wang L., Wilson S.E., Stewart D.B., et al. Marital status and colon cancer outcomes in US surveillance, epidemiology and end results registries: does marriage affect cancer survival by gender and stage?. Cancer Epidemiol 2011, 35:417-422.
45. National Cancer Institute DevCan: probability of developing or dying of cancer software, version 6.5.0; Statistical Research and Applications Branch, [computer program]. http://srab.cancer.gov/devcan.
46. Murphy G., Devesa S.S., Cross A.J., et al. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer 2011, 128:1668-1675.
47. Perdue D.G., Perkins C., Jackson-Thompson J., et al. Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska natives, 1999-2004. Cancer 2008, 113:1179-1190.
48. 2010 Facts & Figures 2010, Accessed February 29, 2012. http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/index.
49. Sack J., Rothman J. Colorectal carcinoma: natural history and management. Hosp Physician 2000, 36:64-73.
50. Segal I. Rarity of colorectal adenomas in the African black population. Eur J Cancer Prev 1998, 7:387-391.
51. Bowel (Colorectal) cancer-UK-incidence statistics, Accessed February 28, 2012. http://info.cancerresearchuk.org/cancerstats/types/bowel/incidence/uk-bowel-cancer-incidence-statistics.
52. Irabor D.O. Colorectal carcinoma: why is there a lower incidence in Nigerians when compared to Caucasians?. J Cancer Epidemiol 2011, 2011:675154.
53. Hitti M. Life Expectancy Pushes Past 78 Years; Death Rate Falls for 11 of 15 Top Causes of Death. WebMD Health News Accessed February 28, 2012. http://www.webmd.com/healthy-aging/news/20080611/life-expectancy-reaches-new-record.
54. Weedon D.D., Shorter R.G., Ilstrup D.M., et al. Crohn's disease and cancer. N Engl J Med 1973, 289:1099-1103.
55. Ekbom A., Helmick C., Zack M., et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990, 336:357-359.
56. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
57. Itzkowitz S.H., Present D.H. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:314-321.
58. Atkin W.S., Morson B.C., Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992, 326:658-662.
59. Knoernschild H.E. Growth rate and malignant potential of colonic polyps: early results. Surg Forum 1963, 14:137-138.
60. Winawer S.J., Zauber A.G., Gerdes H., et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996, 334:82-87.
61. Lyerly H. Carcinoma of the colon, rectum and anus. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice 1997, 971-1032. W. B. Saunders, Philadelphia. D.H. Sabiston, H.K. Lyerly (Eds.).
62. Eide T.J. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 1986, 38:173-176.
63. Senore C., Segnan N., Bonelli L., et al. Predicting proximal advanced neoplasms at screening sigmoidoscopy. Dis Colon Rectum 2004, 47:1331-1340.
64. Crawford J. Gastrointestinal tract. Robbins Pathologic Basis of Disease 1999, 775-843. Saunders/Elsevier, Philadelphia. 6th edition. R. Cotran, V. Kumar, T. Collins, S. Robbins (Eds.).
65. Michal S., Li L., Chen Z. Lifestyle and dietary risk factors for colorectal hyperplastic and adenomatous polyps [abstract]. Cancer Epidemiol Biomarkers Prev 2012, 21(3):563.
66. Burnstein M., Hicks T. Polyps. The ASCRS Textbook of Colon and Rectal Surgery 2007, 362-372. Springer Science+Business Media, LLC, New York. B. Wolff, J. Fleshmam, D. Beck (Eds.).
67. Noffsinger A.E. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 2009, 4:343-364.
68. Longacre T.A., Fenoglio-Preiser C.M. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990, 14:524-537.
69. Matsumoto T., Mizuno M., Shimizu M., et al. Clinicopathological features of serrated adenoma of the colorectum: comparison with traditional adenoma. J Clin Pathol 1999, 52:513-516.
70. Makinen M.J., George S.M., Jernvall P., et al. Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. The J of Pathol 2001, 193:286-294.
71. Mahmoud N., Rombeau J., Ross H., Fry R. Colon and rectum. Sabiston Textbook of Surgery 2004, 1401-1481. Elselvier, Philadelphia, PA. M. Courtney, R. Townsend, D. Beauchamp, B. Evers, K. Mattox (Eds.).
72. Marx J. New colon cancer gene discovered. Science 1993, 260:751-752.
73. Lynch H.T., de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003, 348:919-932.
74. Laken S.J., Petersen G.M., Gruber S.B., et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997, 17:79-83.
75. Bülow S. Results of national registration of familial adenomatous polyposis. Gut 2003, 52:742-746.
76. Hernegger G.S., Moore H.G., Guillem J.G. Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum 2002, 45:127-134. discussion 34-6.
77. Genetic Testing, Accessed February 29, 2012. http://fightlynch.org/dr-genetic-testing.php.
78. Aaltonen L.A., Peltomäki P., Mecklin J.P., et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994, 54:1645-1648.
79. Domingo E., Laiho P., Ollikainen M., et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004, 41:664-668.
80. Bishop M., Downward J., Lane D., et al. Cancer. Molecular Biology of the Cell 1994, 1255-1294. Garland, New York. 3rd edition. B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, J. Watson (Eds.).
81. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
82. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997, 57:808-811.
83. Gryfe R., Kim H., Hsieh E.T., et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000, 342:69-77.
84. Snover D.C. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011, 42:1-10.
85. Siegel R., Ward E., Brawley O., et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61:212-236.
86. Newcomb P.A., Norfleet R.G., Storer B.E., et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992, 84:1572-1575.
87. Winawer S.J., Flehinger B.J., Schottenfeld D., et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993, 85:1311-1318.
88. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977-1981.
89. Müller A.D., Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995, 155:1741-1748.
90. Winawer S.J., Fletcher R.H., Miller L., et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112:594-642.
91. O'Brien M.J., Winawer S.J., Zauber A.G., et al. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990, 98:371-379. The national polyp study.
92. Soetikno R.M., Kaltenbach T., Rouse R.V., et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008, 299:1027-1035.
93. Rembacken B.J., Fujii T., Cairns A., et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet 2000, 355:1211-1214.
94. Saitoh Y., Waxman I., West A.B., et al. Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. Gastroenterology 2001, 120:1657-1665.
95. Wagner J.L. Cost-effectiveness of screening for common cancers. Cancer Metastasis Rev 1997, 16:281-294.
96. Wagner J. From the congressional office of technology assessment. JAMA 1990, 264:2732.
97. Gatto N.M., Frucht H., Sundararajan V., et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003, 95:230-236.
98. Iqbal C.W., Cullinane D.C., Schiller H.J., et al. Surgical management and outcomes of 165 colonoscopic perforations from a single institution. Arch Surg 2008, 143:701-706. discussion 6-7.
99. Rabeneck L., Paszat L.F., Hilsden R.J., et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 2008, 135:1899-1906. 906 e1.
100. Warren J.L., Klabunde C.N., Mariotto A.B., et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 2009, 150:849-857. W152.
101. Rex D.K., Johnson D.A., Anderson J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009, 104:739-750.
102. Rex D.K. Who is the best colonoscopist?. Gastrointest Endosc 2007, 65:145-150.
103. Rex D.K. Quality in colonoscopy: cecal intubation first, then what?. Am J Gastroenterol 2006, 101:732-734.
104. Lieberman D. A call to action-measuring the quality of colonoscopy. N Engl J Med 2006, 355:2588-2589.
105. Rex D.K., Petrini J.L., Baron T.H., et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006, 101:873-885.
106. Rex D.K., Cutler C.S., Lemmel G.T., et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997, 112:24-28.
107. Sanchez W., Harewood G.C., Petersen B.T. Evaluation of polyp detection in relation to procedure time of screening or surveillance colonoscopy. Am J Gastroenterol 2004, 99:1941-1945.
108. Barclay R.L., Vicari J.J., Doughty A.S., et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006, 355:2533-2541.
109. Kaminski M.F., Regula J., Kraszewska E., et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010, 362:1795-1803.
110. Millan M.S., Gross P., Manilich E., et al. Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum 2008, 51:1217-1220.
111. Church J. Adenoma detection rate and the quality of colonoscopy: the sword has two edges. Dis Colon Rectum 2008, 51:520-523.
112. Desch C.E., Benson A.B., Somerfield M.R., et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005, 23:8512-8519.
113. National Comprehensive Cancer Network (NCCN) guidelines, Accessed March 4, 2012. http://www.nccn.org.
114. Taylor A.J., Youker J.E. Imaging in colorectal carcinoma. Semin Oncol 1991, 18:99-110.
115. Horton K.M., Abrams R.A., Fishman E.K. Spiral CT of colon cancer: imaging features and role in management. Radiographics 2000, 20:419-430.
116. Hundt W., Braunschweig R., Reiser M. Evaluation of spiral CT in staging of colon and rectum carcinoma. Eur Radiol 1999, 9:78-84.
117. Isbister W.H., al-Sanea O. The utility of pre-operative abdominal computerized tomography scanning in colorectal surgery. J R Coll Surg Edinb 1996, 41:232-234.
118. Balthazar E.J., Megibow A.J., Hulnick D., et al. Carcinoma of the colon: detection and preoperative staging by CT. Am J Roentgenol 1988, 150:301-306.
119. McAndrew M.R., Saba A.K. Efficacy of routine preoperative computed tomography scans in colon cancer. Am Surg 1999, 65:205-208.
120. Valls C., Lopez E., Gumà A., et al. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. Am J Roentgenol 1998, 170:1341-1347.
121. Jacquet P., Jelinek J.S., Steves M.A., et al. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993, 72:1631-1636.
122. Koh J.L., Yan T.D., Glenn D., et al. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 2009, 16:327-333.
123. Milsom J.W., Jerby B.L., Kessler H., et al. Prospective, blinded comparison of laparoscopic ultrasonography vs. contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery. Dis Colon Rectum 2000, 43:44-49.
124. Stone M.D., Kane R., Bothe A., et al. Intraoperative ultrasound imaging of the liver at the time of colorectal cancer resection. Arch Surg 1994, 129:431-435. discussion 5-6.
125. Machi J., Isomoto H., Yamashita Y., et al. Intraoperative ultrasonography in screening for liver metastases from colorectal cancer: comparative accuracy with traditional procedures. Surgery 1987, 101:678-684.
126. Grossmann I., Avenarius J.K., Mastboom W.J., et al. Preoperative staging with chest CT in patients with colorectal carcinoma: not as a routine procedure. Ann Surg Oncol 2010, 17:2045-2050.
127. Kirke R., Rajesh A., Verma R., et al. Rectal cancer: incidence of pulmonary metastases on thoracic CT and correlation with T staging. J Comput Assist Tomogr 2007, 31:569-571.
128. Winawer S.J., Stewart E.T., Zauber A.G., et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000, 342:1766-1772.
129. Toma J., Paszat L.F., Gunraj N., et al. Rates of new or missed colorectal cancer after barium enema and their risk factors: a population-based study. Am J Gastroenterol 2008, 103:3142-3148.
130. Niekel M.C., Bipat S., Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010, 257:674-684.
131. Flanagan F.L., Dehdashti F., Ogunbiyi O.A., et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998, 227:319-323.
132. Kitajima K., Murakami K., Yamasaki E., et al. Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging 2009, 36:1388-1396.
133. Kalff V., Hicks R.J., Ware R.E., et al. The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002, 43:492-499.
134. Selzner M., Hany T.F., Wildbrett P., et al. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg 2004, 240:1027-1034. discussion 35-6.
135. Chaparro M., Gisbert J.P., Del Campo L., et al. Accuracy of computed tomographic colonography for the detection of polyps and colorectal tumors: a systematic review and meta-analysis. Digestion 2009, 80:1-17.
136. Park S.H., Lee J.H., Lee S.S., et al. CT colonography for detection and characterisation of synchronous proximal colonic lesions in patients with stenosing colorectal cancer. Gut 2011, [Epub ahead of print].
137. Morrin M.M., Farrell R.J., Raptopoulos V., et al. Role of virtual computed tomographic colonography in patients with colorectal cancers and obstructing colorectal lesions. Dis Colon Rectum 2000, 43:303-311.
138. Stoop E.M., de Haan M.C., de Wijkerslooth T.R., et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012, 13:55-64.
139. de Wijkerslooth T.R., de Haan M.C., Stoop E.M., et al. Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial. Gut 2011, [Epub ahead of print].
140. Von Wagner C., Knight K., Halligan S., et al. Patient experiences of colonoscopy, barium enema and CT colonography: a qualitative study. Br J Radiol 2009, 82:13-19.
141. Munikrishnan V., Gillams A.R., Lees W.R., et al. Prospective study comparing multislice CT colonography with colonoscopy in the detection of colorectal cancer and polyps. Dis Colon Rectum 2003, 46:1384-1390.
142. Leksowski K., Rudzinska M., Rudzinski J. Computed tomographic colonography in preoperative evaluation of colorectal tumors: a prospective study. Surg Endosc 2011, 25:2344-2349.
143. Haycock A., Burling D., Wylie P., et al. CT colonography training for radiographers-a formal evaluation. Clin Radiol 2010, 65:997-1004.
144. Fletcher J.G., Chen M.H., Herman B.A., et al. Can radiologist training and testing ensure high performance in CT colonography?. Lessons from the National CT Colonography Trial. Am J Roentgenol 2010, 195:117-125.
145. Neri E., Faggioni L., Cerri F., et al. CT colonography versus double-contrast barium enema for screening of colorectal cancer: comparison of radiation burden. Abdom Imaging 2010, 35:596-601.
146. Brenner D.J., Georgsson M.A. Mass screening with CT colonography: should the radiation exposure be of concern?. Gastroenterology 2005, 129:328-337.
147. Pox C.P., Schmiegel W. Role of CT colonography in colorectal cancer screening: risks and benefits. Gut 2010, 59:692-700.
148. Berrington de Gonzalez A., Kim K.P., Yee J. CT colonography: perforation rates and potential radiation risks. Gastrointest Endosc Clin N Am 2010, 20:279-291.
149. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993, 328:1365-1371.
150. Lindholm E., Brevinge H., Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008, 95:1029-1036.
151. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004, 351:2704-2714.
152. Sanford K.W., McPherson R.A. Fecal occult blood testing. Clin Lab Med 2009, 29:523-541.
153. Denis B., Gendre I., Aman F., et al. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial). Eur J Cancer 2009, 45:3282-3290.
154. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007, 56:210-214.
155. Parra-Blanco A., Gimeno-García A.Z., Quintero E., et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 2010, 45:703-712.
156. Dancourt V., Lejeune C., Lepage C., et al. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008, 44:2254-2258.
157. Zhu M.M., Xu X.T., Nie F., et al. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis. J Dig Dis 2010, 11:148-160.
158. Allison J.E., Sakoda L.C., Levin T.R., et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007, 99:1462-1470.
159. Dong S.M., Traverso G., Johnson C., et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001, 93:858-865.
160. Calistri D., Rengucci C., Bocchini R., et al. Fecal multiple molecular tests to detect colorectal cancer in stool. Clin Gastroenterol Hepatol 2003, 1:377-383.
161. Chen W.D., Han Z.J., Skoletsky J., et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005, 97:1124-1132.
162. Nagasaka T., Tanaka N., Cullings H.M., et al. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst 2009, 101:1244-1258.
163. Sidransky D., Tokino T., Hamilton S.R., et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992, 256:102-105.
164. Ahlquist D.A., Skoletsky J.E., Boynton K.A., et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000, 119:1219-1227.
165. Tagore K.S., Lawson M.J., Yucaitis J.A., et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clin Colorectal Cancer 2003, 3:47-53.
166. Song K., Fendrick A.M., Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 2004, 126:1270-1279.
167. Haug U., Hundt S., Brenner H. Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study. Br J Cancer 2008, 99:133-135.
168. Shastri Y.M., Naumann M., Oremek G.M., et al. Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia. Int J Cancer 2006, 119:2651-2656.
169. Koss K., Maxton D., Jankowski J.A. Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention. Colorectal Dis 2008, 10:244-248.
170. Li R., Liu J., Xue H., et al. Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis. Int J Cancer 2012, [Epub ahead of print].
171. Duthie G.S., Foster M.E., Price-Thomas J.M., et al. Bowel preparation or not for elective colorectal surgery. J R Coll Surg Edinb 1990, 35:169-171.
172. Solla J.A., Rothenberger D.A. Preoperative bowel preparation. A survey of colon and rectal surgeons. Dis Colon Rectum 1990, 33:154-159.
173. Beck D.E., Fazio V.W. Current preoperative bowel cleansing methods. Results of a survey. Dis Colon Rectum 1990, 33:12-15.
174. Zmora O., Wexner S.D., Hajjar L., et al. Trends in preparation for colorectal surgery: survey of the members of the American Society of Colon and Rectal Surgeons. Am Surg 2003, 69:150-154.
175. Nichols R.L., Smith J.W., Garcia R.Y., et al. Current practices of preoperative bowel preparation among North American colorectal surgeons. Clin Infect Dis 1997, 24:609-619.
176. Oliveira L., Wexner S.D., Daniel N., et al. A prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions. Dis Colon Rectum 1997, 40:585-591. Mechanical bowel preparation for elective colorectal surgery.
177. Baum M.L., Anish D.S., Chalmers T.C., et al. A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med 1981, 305:795-799.
178. Song F., Glenny A.M. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br J Surg 1998, 85:1232-1241.
179. Memon M.A., Devine J., Freeney J., From S.G. Is mechanical bowel preparation really necessary for elective left sided colon and rectal surgery?. Int J Colorectal Dis 1997, 12:298-302.
180. Curran T.J., Borzotta A.P. Complications of primary repair of colon injury: literature review of 2,964 cases. Am J Surg 1999, 177:42-47.
181. De U., Ghosh S. Single stage primary anastomosis without colonic lavage for left-sided colonic obstruction due to acute sigmoid volvulus: a prospective study of one hundred and ninety-seven cases. ANZ J Surg 2003, 73:390-392.
182. van Geldere D., Fa-Si-Oen P., Noach L.A., et al. Complications after colorectal surgery without mechanical bowel preparation. J Am Coll Surg 2002, 194:40-47.
183. Brownson P., Jenkins S., Nott D., et al. Mechanical bowel preparation before colorectal surgery: results of a prospective randomized trial [abstract]. Br J Surg 1992, 79:461-462.
184. Bucher P., Soravia C., Gervaz P., et al. Post-operative complications after elective colorectal surgery in regards of bowel preparation: a randomized trial [abstract]. Gastroenterology 2003, 124:817.
185. Fillmann E., Fillmann H., Fillmann L. Elective colorectal surgery without mechanical prepare. Rev Bras Colo-Proct 1995, 15:70-71.
186. Santos J.C., Batista J., Sirimarco M.T., et al. Prospective randomized trial of mechanical bowel preparation in patients undergoing elective colorectal surgery. Br J Surg 1994, 81:1673-1676.
187. Miettinen R.P., Laitinen S.T., Makela J.T., et al. Bowel preparation with oral polyethylene glycol electrolyte solution vs. no preparation in elective open colorectal surgery: prospective, randomized study. Dis Colon Rectum 2000, 43:669-675. discussion 75-7.
188. Zmora O., Mahajna A., Bar-Zakai B., et al. Colon and rectal surgery without mechanical bowel preparation: a randomized prospective trial. Ann Surg 2003, 237:363-367.
189. Burke P., Mealy K., Gillen P., et al. Requirement for bowel preparation in colorectal surgery. Br J Surg 1994, 81:907-910.
190. Platell C., Hall J. What is the role of mechanical bowel preparation in patients undergoing colorectal surgery?. Dis Colon Rectum 1998, 41:875-882. discussion 82-3.
191. Hall J.C., Mills B., Nguyen H., et al. Methodologic standards in surgical trials. Surgery 1996, 119:466-472.
192. Wille-Jørgensen P., Guenaga K.F., Castro A.A., et al. Clinical value of preoperative mechanical bowel cleansing in elective colorectal surgery: a systematic review. Dis Colon Rectum 2003, 46:1013-1020.
193. Gründel K., Schwenk W., Böhm B., et al. Improvements in mechanical bowel preparation for elective colorectal surgery. Dis Colon Rectum 1997, 40:1348-1352.
194. Bucher P., Mermillod B., Gervaz P., et al. Mechanical bowel preparation for elective colorectal surgery: a meta-analysis. Arch Surg 2004, 139:1359-1364. discussion 65.
195. Nichols R.L., Condon R.E. Preoperative preparation of the colon. Surg Gynecol Obstet 1971, 132:323-337.
196. Bartlett J.G., Condon R.E., Gorbach S.L., et al. Veterans Administration cooperative study on bowel preparation for elective colorectal operations: impact of oral antibiotic regimen on colonic flora, wound irrigation cultures and bacteriology of septic complications. Ann Surg 1978, 188:249-254.
197. Page C.P., Bohnen J.M., Fletcher J.R., et al. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 1993, 128:79-88.
198. Rosenberg I.L., Graham N.G., De Dombal F.T., et al. Preparation of the intestine in patients undergoing major large-bowel surgery, mainly for neoplasms of the colon and rectum. Br J Surg 1971, 58:266-269.
199. Evans C., Pollock A.V. The reduction of surgical wound infections by prophylactic parenteral cephaloridine. A controlled clinical trial. Br J Surg 1973, 60:434-437.
200. Clarke J.S., Condon R.E., Bartlett J.G., et al. Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg 1977, 186:251-259.
201. Matheson D.M., Arabi Y., Baxter-Smith D., et al. Randomized multicentre trial of oral bowel preparation and antimicrobials for elective colorectal operations. Br J Surg 1978, 65:597-600.
202. Condon R.E., Bartlett J.G., Nichols R.L., et al. Preoperative prophylactic cephalothin fails to control septic complications of colorectal operations: results of controlled clinical trial. A Veterans Administration Cooperative Study. Am J Surg 1979, 137:68-74.
203. Coppa G.F., Eng K. Factors involved in antibiotic selection in elective colon and rectal surgery. Surgery 1988, 104:853-858.
204. Schoetz D.J., Roberts P.L., Murray J.J., et al. Addition of parenteral cefoxitin to regimen of oral antibiotics for elective colorectal operations. A randomized prospective study. Ann Surg 1990, 212:209-212.
205. Contant C.M., Hop W.C., van't Sant H.P., et al. Mechanical bowel preparation for elective colorectal surgery: a multicentre randomised trial. Lancet 2007, 370:2112-2117.
206. Jung B., Påhlman L., Nyström P.O., et al. Multicentre randomized clinical trial of mechanical bowel preparation in elective colonic resection. Br J Surg 2007, 94:689-695.
207. Englesbe M.J., Brooks L., Kubus J., et al. A statewide assessment of surgical site infection following colectomy: the role of oral antibiotics. Ann Surg 2010, 252:514-519. discussion 9-20.
208. Fry D.E. Colon preparation and surgical site infection. Am J Surg 2011, 202:225-232.
209. Veenhof A.A., Sietses C., Giannakopoulos G.F., et al. Preoperative polyethylene glycol versus a single enema in elective bowel surgery. Dig Surg 2007, 24:54-57. discussion 7-8.
210. Davis J.M., Kuo Y.H., Ahmed N., et al. Report card on surgical care improvement project (SCIP): nationwide inpatient sample infection data 2001-2006. Surg Infect (Larchmt) 2011, 12:429-434.
211. Senagore A.J., Emery T., Luchtefeld M., et al. Fluid management for laparoscopic colectomy: a prospective, randomized assessment of goal-directed administration of balanced salt solution or hetastarch coupled with an enhanced recovery program. Dis Colon Rectum 2009, 52:1935-1940.
212. Rahbari N.N., Zimmermann J.B., Schmidt T., et al. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg 2009, 96:331-341.
213. Futier E., Constantin J.M., Petit A., et al. Conservative vs restrictive individualized goal-directed fluid replacement strategy in major abdominal surgery: a prospective randomized trial. Arch Surg 2010, 145:1193-1200.
214. Wenkui Y., Ning L., Jianfeng G., et al. Restricted peri-operative fluid administration adjusted by serum lactate level improved outcome after major elective surgery for gastrointestinal malignancy. Surgery 2010, 147:542-552.
215. Chappell D., Jacob M., Hofmann-Kiefer K., et al. A rational approach to perioperative fluid management. Anesthesiology 2008, 109:723-740.
216. Multicentre study on peri- and postoperative central venous oxygen saturation in high-risk surgical patients. Crit Care 2006, 10:R158. Collaborative Study Group on Perioperative ScvO2 Monitoring.
217. Abbas S.M., Hill A.G. Systematic review of the literature for the use of oesophageal Doppler monitor for fluid replacement in major abdominal surgery. Anaesthesia 2008, 63:44-51.
218. Hiltebrand L.B., Kimberger O., Arnberger M., et al. Crystalloids versus colloids for goal-directed fluid therapy in major surgery. Crit Care 2009, 13:R40.
219. Kimberger O., Arnberger M., Brandt S., et al. Goal-directed colloid administration improves the microcirculation of healthy and perianastomotic colon. Anesthesiology 2009, 110:496-504.
220. Schilling P.L., Dimick J.B., Birkmeyer J.D. Prioritizing quality improvement in general surgery. J Am Coll Surg 2008, 207:698-704.
221. Birkmeyer J.D., Dimick J.B., Staiger D.O. Operative mortality and procedure volume as predictors of subsequent hospital performance. Ann Surg 2006, 243:411-417.
222. Polk H.C., Birkmeyer J., Hunt D.R., et al. Quality and safety in surgical care. Ann Surg 2006, 243:439-448.
223. Khuri S.F., Henderson W.G., Daley J., et al. The patient safety in surgery study: background, study design, and patient populations. J Am Coll Surg 2007, 204:1089-1102.
224. Main D.S., Henderson W.G., Pratte K., et al. Relationship of processes and structures of care in general surgery to postoperative outcomes: a descriptive analysis. J Am Coll Surg 2007, 204:1157-1165.
225. Main D.S., Cavender T.A., Nowels C.T., et al. Relationship of processes and structures of care in general surgery to postoperative outcomes: a qualitative analysis. J Am Coll Surg 2007, 204:1147-1156.
226. Schifftner T.L., Grunwald G.K., Henderson W.G., et al. Relationship of processes and structures of care in general surgery to postoperative outcomes: a hierarchical analysis. J Am Coll Surg 2007, 204:1166-1177.
227. Rowell K.S., Turrentine F.E., Hutter M.M., et al. Use of national surgical quality improvement program data as a catalyst for quality improvement. J Am Coll Surg 2007, 204:1293-1300.
228. Kehlet H., Wilmore D.W. Multimodal strategies to improve surgical outcome. Am J Surg 2002, 183:630-641.
229. Kehlet H., Dahl J.B. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet 2003, 362:1921-1928.
230. Bratzler D.W., Houck P.M., et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004, 38:1706-1715. Surgical Infection Prevention Guidelines Writers Workgroup.
231. Petrowsky H., Demartines N., Rousson V., et al. Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg 2004, 240:1074-1084. discussion 84-5.
232. Kawai M., Tani M., Terasawa H., et al. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg 2006, 244:1-7.
233. Yeh C.Y., Changchien C.R., Wang J.Y., et al. Pelvic drainage and other risk factors for leakage after elective anterior resection in rectal cancer patients: a prospective study of 978 patients. Ann Surg 2005, 241:9-13.
234. Nelson R., Edwards S., Tse B. Prophylactic nasogastric decompression after abdominal surgery. Cochrane Database Syst Rev 2007, CD004929.
235. Wilmore D.W. From Cuthbertson to fast-track surgery: 70 years of progress in reducing stress in surgical patients. Ann Surg 2002, 236:643-648.
236. Kehlet H. Labat lecture 2005: surgical stress and postoperative outcome-from here to where?. Reg Anesth Pain Med 2006, 31:47-52.
237. Sessler D.I. Complications and treatment of mild hypothermia. Anesthesiology 2001, 95:531-543.
238. Wong P.F., Kumar S., Bohra A., et al. Randomized clinical trial of perioperative systemic warming in major elective abdominal surgery. Br J Surg 2007, 94:421-426.
239. Holte K., Kehlet H. Epidural anaesthesia and analgesia-effects on surgical stress responses and implications for postoperative nutrition. Clin Nutr 2002, 21:199-206.
240. Svanfeldt M., Thorell A., Hausel J., et al. Randomized clinical trial of the effect of preoperative oral carbohydrate treatment on postoperative whole-body protein and glucose kinetics. Br J Surg 2007, 94:1342-1350.
241. Henriksen M.G., Hessov I., Dela F., et al. Effects of preoperative oral carbohydrates and peptides on postoperative endocrine response, mobilization, nutrition and muscle function in abdominal surgery. Acta Anaesthesiol Scand 2003, 47:191-199.
242. Yuill K.A., Richardson R.A., Davidson H.I., et al. The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively-a randomised clinical trial. Clin Nutr 2005, 24:32-37.
243. Noblett S.E., Watson D.S., Huong H., et al. Pre-operative oral carbohydrate loading in colorectal surgery: a randomized controlled trial. Colorectal Dis 2006, 8:563-569.
244. Wu C.L., Rowlingson A.J., Partin A.W., et al. Correlation of postoperative pain to quality of recovery in the immediate postoperative period. Reg Anesth Pain Med 2005, 30:516-522.
245. Kehlet H. Postoperative opioid sparing to hasten recovery: what are the issues?. Anesthesiology 2005, 102:1083-1085.
246. White P.F., Kehlet H., Neal J.M., et al. The role of the anesthesiologist in fast-track surgery: from multimodal analgesia to perioperative medical care. Anesth Analg 2007, 104:1380-1396. table of contents.
247. Levy B.F., Scott M.J., Fawcett W.J., et al. 23-hour-stay laparoscopic colectomy. Dis Colon Rectum 2009, 52:1239-1243.
248. Röstlund T., Kehlet H. High-dose local infiltration analgesia after hip and knee replacement-what is it, why does it work, and what are the future challenges?. Acta Orthop 2007, 78:159-161.
249. Liu S.S., Richman J.M., Thirlby R.C., et al. Efficacy of continuous wound catheters delivering local anesthetic for postoperative analgesia: a quantitative and qualitative systematic review of randomized controlled trials. J Am Coll Surg 2006, 203:914-932.
250. Kehlet H., Liu S.S. Continuous local anesthetic wound infusion to improve postoperative outcome: back to the periphery?. Anesthesiology 2007, 107:369-371.
251. Richman J.M., Liu S.S., Courpas G., et al. Does continuous peripheral nerve block provide superior pain control to opioids?. A meta-analysis. Anesth Analg 2006, 102:248-257.
252. Block B.M., Liu S.S., Rowlingson A.J., et al. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA 2003, 290:2455-2463.
253. Vlug M.S., Bartels S.A., Wind J., et al. Which fast track elements predict early recovery after colon cancer surgery?. Colorectal Dis 2011, [Epub ahead of print].
254. Wind J., Polle S.W., Fung K., et al. Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg 2006, 93:800-809.
255. Khoo C.K., Vickery C.J., Forsyth N., et al. A prospective randomized controlled trial of multimodal perioperative management protocol in patients undergoing elective colorectal resection for cancer. Ann Surg 2007, 245:867-872.
256. Kehlet H. Fast-track colorectal surgery. Lancet 2008, 371:791-793.
257. Delaney C.P., Zutshi M., Senagore A.J., et al. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 2003, 46:851-859.
258. Andersen J., Hjort-Jakobsen D., Christiansen P.S., et al. Readmission rates after a planned hospital stay of 2 versus 3 days in fast-track colonic surgery. Br J Surg 2007, 94:890-893.
259. Aiken L.H., Clarke S.P., Cheung R.B., et al. Educational levels of hospital nurses and surgical patient mortality. JAMA 2003, 290:1617-1623.
260. Tourangeau A.E., Cranley L.A., Jeffs L. Impact of nursing on hospital patient mortality: a focused review and related policy implications. Qual Saf Health Care 2006, 15:4-8.
261. Kehlet H., Büchler M.W., Beart R.W., et al. Care after colonic operation-is it evidence-based?. Results from a multinational survey in Europe and the United States. J Am Coll Surg 2006, 202:45-54.
262. Slim K., Panis Y., Chipponi J. Half of the currecnt practice of gastrointestinal surgery is against the evidence: a survery of the French Society of Digestive Surgery. J Gastrointest Surg 2004, 8:1079-1082.
263. Walter C.J., Smith A., Guillou P. Perceptions of the application of fast-track surgical principles by general surgeons. Ann R Coll Surg Engl 2006, 88:191-195.
264. Lassen K., Hannemann P., Ljungqvist O., et al. Patterns in current perioperative practice: survey of colorectal surgeons in five northern European countries. BMJ 2005, 330:1420-1421.
265. Hannemann P., Lassen K., Hausel J., et al. Patterns in current anaesthesiological peri-operative practice for colonic resections: a survey in five northern-European countries. Acta Anaesthesiol Scand 2006, 50:1152-1160.
266. Maessen J., Dejong C.H., Hausel J., et al. A protocol is not enough to implement an enhanced recovery programme for colorectal resection. Br J Surg 2007, 94:224-231.
267. Birkmeyer N.J., Share D., Campbell D.A., et al. Partnering with payers to improve surgical quality: the Michigan plan. Surgery 2005, 138:815-820.
268. Rosenthal M.B., Dudley R.A. Pay-for-performance: will the latest payment trend improve care?. JAMA 2007, 297:740-744.
269. Jacobs M., Verdeja J.C., Goldstein H.S. Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc 1991, 1:144-150.
270. Milsom J.W., Böhm B., Hammerhofer K.A., et al. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J Am Coll Surg 1998, 187:46-54. discussion 5.
271. Ortega A.E., Beart R.W., Steele G.D., et al. Laparoscopic bowel surgery registry. Preliminary results. Dis Colon Rectum 1995, 38:681-685. discussion 5-6.
272. Wexner S.D., Cohen S.M. Port site metastases after laparoscopic colorectal surgery for cure of malignancy. Br J Surg 1995, 82:295-298.
273. Hughes E.S., McDermott F.T., Polglase A.L., et al. Tumor recurrence in the abdominal wall scar tissue after large-bowel cancer surgery. Dis Colon Rectum 1983, 26:571-572.
274. Reilly W.T., Nelson H., Schroeder G., et al. Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum 1996, 39:200-207.
275. Vukasin P., Ortega A.E., Greene F.L., et al. Wound recurrence following laparoscopic colon cancer resection. Results of the American Society of Colon and Rectal Surgeons Laparoscopic Registry. Dis Colon Rectum 1996, 39:S20-S23.
276. Lacy A.M., García-Valdecasas J.C., Delgado S., et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002, 359:2224-2229.
277. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004, 350:2050-2059. Clinical Outcomes of Surgical Therapy Study Group.
278. Veldkamp R., Kuhry E., Hop W.C., et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 2005, 6:477-484.
279. Guillou P.J., Quirke P., Thorpe H., et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005, 365:1718-1726.
280. Wood T.F., Saha S., Morton D.L., et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001, 8:150-157.
281. Joosten J.J., Strobbe L.J., Wauters C.A., et al. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999, 86:482-486.
282. Kelder W., Braat A.E., Karrenbeld A., et al. The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands. Int J Colorectal Dis 2007, 22:1509-1514.
283. Viehl C.T., Guller U., Cecini R., et al. Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol 2012, [Epub ahead of print].
284. Paramo J.C., Summerall J., Poppiti R., et al. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 2002, 9:550-554.
285. Bembenek A.E., Rosenberg R., Wagler E., et al. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 2007, 245:858-863.
286. Bertagnolli M., Miedema B., Redston M., et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 2004, 240:624-628. discussion 8-30.
287. Stojadinovic A., Nissan A., Protic M., et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 2007, 245:846-857.
288. Lim S.J., Feig B.W., Wang H., et al. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol 2008, 15:46-51.
289. Fisher E.R., Colangelo L., Wieand S., et al. Lack of influence of cytokeratin-positive mini micrometastases in "negative node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01. Dis Colon Rectum 2003, 46:1021-1025. discussion 5-6.
290. Rosenberg R., Friederichs J., Gertler R., et al. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis 2004, 19:430-437.
291. Waters J.A., Rapp B.M., Guzman M.J., et al. Single-port laparoscopic right hemicolectomy: the first 100 resections. Dis Colon Rectum 2012, 55:134-139.
292. Katsuno G., Fukunaga M., Nagakari K., et al. Single-incision laparoscopic colectomy for colon cancer: early experience with 31 cases. Dis Colon Rectum 2011, 54:705-710.
293. Makino T., Milsom J.W., Lee S.W. Feasibility and safety of single-incision laparoscopic colectomy: a systematic review. Ann Surg 2012, 255(4):667-676.
294. Chew M.H., Wong M.T., Lim B.Y., et al. Evaluation of current devices in single-incision laparoscopic colorectal surgery: a preliminary experience in 32 consecutive cases. World J Surg 2011, 35:873-880.
295. Singh J., Podolsky E.R., Castellanos A.E., et al. Optimizing single port surgery: a case report and review of technique in colon resection. Int J Med Robot 2011, 7:127-130.
296. Gaujoux S., Maggiori L., Bretagnol F., et al. Safety, feasibility, and short-term outcomes of single port access colorectal surgery: a single institutional case-matched study. J Gastrointest Surg 2012, 16:629-634.
297. Kim S.J., Ryu G.O., Choi B.J., et al. The short-term outcomes of conventional and single-port laparoscopic surgery for colorectal cancer. Ann Surg 2011, 254:933-940.
298. Papaconstantinou H.T., Thomas J.S. Single-incision laparoscopic colectomy for cancer: assessment of oncologic resection and short-term outcomes in a case-matched comparison with standard laparoscopy. Surgery 2011, 150:820-827.
299. Ballantyne G.H. The pitfalls of laparoscopic surgery: challenges for robotics and telerobotic surgery. Surg Laparosc Endosc Percutan Tech 2002, 12:1-5.
300. Delaney C.P., Lynch A.C., Senagore A.J., et al. Comparison of robotically performed and traditional laparoscopic colorectal surgery. Dis Colon Rectum 2003, 46:1633-1639.
301. D'Annibale A., Morpurgo E., Fiscon V., et al. Robotic and laparoscopic surgery for treatment of colorectal diseases. Dis Colon Rectum 2004, 47:2162-2168.
302. Luca F., Ghezzi T.L., Valvo M., et al. Surgical and pathological outcomes after right hemicolectomy: case-matched study comparing robotic and open surgery. Int J Med Robot 2011, [Epub ahead of print].
303. Hashizume M., Tsugawa K. Robotic surgery and cancer: the present state, problems and future vision. Jpn J Clin Oncol 2004, 34:227-237.
304. Ballantyne G.H. Robotic surgery, telerobotic surgery, telepresence, and telementoring. Review of early clinical results. Surg Endosc 2002, 16:1389-1402.
305. Spinoglio G., Summa M., Priora F., et al. Robotic colorectal surgery: first 50 cases experience. Dis Colon Rectum 2008, 51:1627-1632.
306. Dunn K.B., Trudel J.L. Colorectal cancer: adjuvant therapy. The ASCRS Textbook of Colon and Rectal Surgery 2011, 773-782. Springer, New York. 2nd edition. D.E. Beck, P.L. Roberts, T.J. Saclarides, A.J. Senagore, M.J. Stamos, S.D. Wexner (Eds.).
307. Wolmark N., Rockette H., Fisher B., et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993, 11:1879-1887.
308. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International multicentre pooled analysis of colon cancer trials (IMPACT) investigators. Lancet 1995, 345:939-944.
309. O'Connell M.J., Mailliard J.A., Kahn M.J., et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997, 15:246-250.
310. André T., Boni C., Mounedji-Boudiaf L., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004, 350:2343-2351.
311. Andre T., Boni C., Navarro M., et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009, 27:3109-3116.
312. Schrag D., Rifas-Shiman S., Saltz L., et al. Adjuvant chemotherapy use for medicare beneficiaries with stage II colon cancer. J Clin Oncol 2002, 20:3999-4005.
313. Wu X., Zhang J., He X., et al. Postoperative adjuvant chemotherapy for stage II colorectal cancer: a systematic review of 12 randomized controlled trials. J Gastrointest Surg 2012, 16:646-655.
314. McKenzie S., Nelson R., Mailey B., et al. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer. Cancer 2011, 117:5493-5499.
315. Jee S.H., Moon S.M., Shin U.S., et al. Effectiveness of adjuvant chemotherapy with 5-FU/leucovorin and prognosis in stage II Colon cancer. J Korean Soc Coloproctol 2011, 27:322-328.
316. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004, 239:818-825. discussion 25-7.
317. Poultsides G.A., Servais E.L., Saltz L.B., et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009, 27:3379-3384.
318. Nitzkorski J.R., Farma J.M., Watson J.C., et al. Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection. Ann Surg Oncol 2012, 19:379-383.
319. Venderbosch S., de Wilt J.H., Teerenstra S., et al. Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol 2011, 18:3252-3260.
320. Stillwell A.P., Buettner P.G., Ho Y.H. Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 2010, 34:797-807.
321. Van Cutsem E., Köhne C.H., Hitre E., et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009, 360:1408-1417.
322. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342.
323. Tol J., Koopman M., Cats A., et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009, 360:563-572.
324. Stintzing S., Fischer von Weikersthal L., Decker T., et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306. Ann Oncol 2012, [Epub ahead of print].
325. Angenete E., Asplund D., Bergstrom M., et al. Stenting for colorectal cancer obstruction compared to surgery-a study of consecutive patients in a single institution. Int J Colorectal Dis 2011, [Epub ahead of print].
326. Jiménez-Pérez J., Casellas J., García-Cano J., et al. Colonic stenting as a bridge to surgery in malignant large-bowel obstruction: a report from two large multinational registries. Am J Gastroenterol 2011, 106:2174-2180.
327. Baron T.H. Colonic stenting: technique, technology, and outcomes for malignant and benign disease. Gastrointest Endosc Clin N Am 2005, 15:757-771.
328. Meisner S., González-Huix F., Vandervoort J.G., et al. Self-expandable metal stents for relieving malignant colorectal obstruction: short-term safety and efficacy within 30 days of stent procedure in 447 patients. Gastrointest Endosc 2011, 74:876-884.
329. Lee K.M., Shin S.J., Hwang J.C., et al. Comparison of uncovered stent with covered stent for treatment of malignant colorectal obstruction. Gastrointest Endosc 2007, 66:931-936.
330. Yoon J.Y., Jung Y.S., Hong S.P., et al. Clinical outcomes and risk factors for technical and clinical failures of self-expandable metal stent insertion for malignant colorectal obstruction. Gastrointest Endosc 2011, 74:858-868.
331. Jung M.K., Park S.Y., Jeon S.W., et al. Factors associated with the long-term outcome of a self-expandable colon stent used for palliation of malignant colorectal obstruction. Surg Endosc 2010, 24:525-530.
332. Small A.J., Coelho-Prabhu N., Baron T.H. Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors. Gastrointest Endosc 2010, 71:560-572.
333. Luigiano C., Ferrara F., Fabbri C., et al. Through-the-scope large diameter self-expanding metal stent placement as a safe and effective technique for palliation of malignant colorectal obstruction: a single center experience with a long-term follow-up. Scand J Gastroenterol 2011, 46:591-596.
334. Lee H.J., Hong S.P., Cheon J.H., et al. Long-term outcome of palliative therapy for malignant colorectal obstruction in patients with unresectable metastatic colorectal cancers: endoscopic stenting versus surgery. Gastrointest Endosc 2011, 73:535-542.
335. Karoui M., Charachon A., Delbaldo C., et al. Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. Arch Surg 2007, 142:619-623. discussion 23.
336. Ho K.S., Quah H.M., Lim J.F., et al. Endoscopic stenting and elective surgery versus emergency surgery for left-sided malignant colonic obstruction: a prospective randomized trial. Int J Colorectal Dis 2012, 27(3):355-362.
337. Sagar J. Colorectal stents for the management of malignant colonic obstructions. Cochrane Database Syst Rev 2011, 11. CD007378 [Epub ahead of print].
338. Yao L.Q., Zhong Y.S., Xu M.D., et al. Self-expanding metallic stents drainage for acute proximal colon obstruction. World J Gastroenterol 2011, 17:3342-3346.
339. Targownik L.E., Spiegel B.M., Sack J., et al. Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: a decision analysis. Gastrointest Endosc 2004, 60:865-874.
340. Xinopoulos D., Dimitroulopoulos D., Theodosopoulos T., et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions?. Results of a study and cost-effectiveness analysis. Surg Endosc 2004, 18:421-426.
341. Kaiser A.M., Katkhouda N. Laparoscopic management of the perforated viscus. Semin Laparosc Surg 2002, 9:46-53.
342. Dastur J.K., Forshaw M.J., Modarai B., et al. Comparison of short-and long-term outcomes following either insertion of self-expanding metallic stents or emergency surgery in malignant large bowel obstruction. Tech Coloproctol 2008, 12:51-55.
343. Sjo O.H., Larsen S., Lunde O.C., et al. Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis 2009, 11:733-739.
344. Alves A., Panis Y., Mathieu P., et al. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg 2005, 140:278-283.
345. Kaiser A.M. McGraw-Hill Manual Colorectal Surgery 2009, McGraw-Hill Companies, New York.
346. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. The SCOTIA Study Group. Subtotal colectomy versus on-table irrigation and anastomosis.[see comment]. Br J Surg 1995, 82:1622-1627. Anonymous.
347. Aslar A.K., Ozdemir S., Mahmoudi H., et al. Analysis of 230 cases of emergent surgery for obstructing colon cancer-lessons learned. J Gastrointest Surg 2011, 15:110-119.
348. Mackay C.D., Craig W., Hussey J.K., et al. Self-expanding metallic stents for large bowel obstruction. Br J Surg 2011, 98:1625-1629.